Source disclosure: February 16, 2026
Immuno-Biological Laboratories Co., Ltd. [4570.T]
TOKYO, Feb 16 (Pulse News Wire) – Immuno-biological Laboratories CO.,LTD. (4570.T) announced today that it, along with National University Corporation Kumamoto University, National Institute of Biomedical Innovation, Health and Nutrition, and CURED Inc., received notification from the Korean Intellectual Property Office granting a patent for their anti-HIV antibody and its manufacturing method.
The application details areas follows: Name: Anti-HIV Antibody and Its Manufacturing Method Application Number: 10-2,021-7,013,696 Publication Number: 488 Applicants: Immuno-biological Laboratories CO.,LTD., Kumamoto University, National Institute of Biomedical Innovation, Health and Nutrition, and CURED Inc.
It is noted that the number of HIV-positive individuals in South Korea is approximately half that of Japan. Regarding future prospects, the company does not anticipate any impact on its consolidated performance for the fiscal year ending March 2026.
However, should any significant developments arise, the company pledges to promptly inform stakeholders.
AI-translated content. 🟢 Confidence: High See terms • Original filing